| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncolytic Virotherapy | 15 | 2024 | 515 | 4.480 |
Why?
|
| Sumoylation | 8 | 2019 | 83 | 3.740 |
Why?
|
| Oncolytic Viruses | 10 | 2024 | 343 | 2.560 |
Why?
|
| Glioblastoma | 17 | 2024 | 3482 | 2.070 |
Why?
|
| Cerebellar Neoplasms | 4 | 2023 | 585 | 2.010 |
Why?
|
| Glioma | 13 | 2024 | 3420 | 1.820 |
Why?
|
| Brain Neoplasms | 26 | 2024 | 8984 | 1.580 |
Why?
|
| Herpesvirus 1, Human | 7 | 2023 | 753 | 1.560 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 6 | 2020 | 68 | 1.290 |
Why?
|
| Neural Stem Cells | 7 | 2021 | 884 | 1.210 |
Why?
|
| Brain Ischemia | 6 | 2023 | 3127 | 0.920 |
Why?
|
| Medulloblastoma | 2 | 2019 | 677 | 0.890 |
Why?
|
| Hyperostosis | 1 | 2022 | 29 | 0.850 |
Why?
|
| Simplexvirus | 3 | 2024 | 803 | 0.760 |
Why?
|
| SUMO-1 Protein | 2 | 2018 | 35 | 0.750 |
Why?
|
| Neurosurgical Procedures | 8 | 2024 | 2056 | 0.720 |
Why?
|
| Aicardi Syndrome | 1 | 2020 | 16 | 0.720 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 190 | 0.710 |
Why?
|
| Essential Tremor | 1 | 2022 | 157 | 0.700 |
Why?
|
| Spinal Injuries | 3 | 2021 | 300 | 0.690 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2023 | 1032 | 0.640 |
Why?
|
| Corpus Callosum | 2 | 2020 | 749 | 0.630 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2024 | 9274 | 0.630 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2019 | 313 | 0.630 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2019 | 96 | 0.610 |
Why?
|
| Intracranial Aneurysm | 6 | 2024 | 1276 | 0.610 |
Why?
|
| DiGeorge Syndrome | 1 | 2019 | 185 | 0.600 |
Why?
|
| Stroke | 7 | 2023 | 9945 | 0.600 |
Why?
|
| Choroid Plexus | 1 | 2020 | 237 | 0.580 |
Why?
|
| Supratentorial Neoplasms | 1 | 2018 | 159 | 0.580 |
Why?
|
| Topotecan | 1 | 2017 | 132 | 0.570 |
Why?
|
| Spine | 3 | 2024 | 1111 | 0.560 |
Why?
|
| Hemangiosarcoma | 1 | 2019 | 218 | 0.560 |
Why?
|
| Hyperplasia | 1 | 2020 | 1158 | 0.560 |
Why?
|
| Hydrocephalus | 2 | 2020 | 763 | 0.540 |
Why?
|
| Craniotomy | 5 | 2023 | 741 | 0.540 |
Why?
|
| Stereotaxic Techniques | 1 | 2018 | 549 | 0.530 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 429 | 0.530 |
Why?
|
| Neuroprotective Agents | 3 | 2021 | 961 | 0.520 |
Why?
|
| Bone Neoplasms | 3 | 2020 | 2532 | 0.500 |
Why?
|
| Cerebral Revascularization | 3 | 2022 | 249 | 0.500 |
Why?
|
| Cysteine Endopeptidases | 1 | 2018 | 548 | 0.490 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 1387 | 0.480 |
Why?
|
| Temporal Bone | 1 | 2019 | 683 | 0.480 |
Why?
|
| Ubiquitination | 1 | 2019 | 1010 | 0.480 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 2014 | 36 | 0.480 |
Why?
|
| Ganglioneuroma | 1 | 2014 | 53 | 0.470 |
Why?
|
| Moyamoya Disease | 3 | 2022 | 255 | 0.470 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 1977 | 0.470 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2019 | 917 | 0.470 |
Why?
|
| Protease Inhibitors | 1 | 2018 | 755 | 0.460 |
Why?
|
| Ilium | 1 | 2014 | 154 | 0.450 |
Why?
|
| Radiotherapy | 1 | 2020 | 1505 | 0.440 |
Why?
|
| Spinal Canal | 1 | 2012 | 41 | 0.420 |
Why?
|
| Glucose | 5 | 2019 | 4361 | 0.420 |
Why?
|
| Humans | 111 | 2024 | 760261 | 0.400 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.400 |
Why?
|
| Decompressive Craniectomy | 2 | 2023 | 76 | 0.400 |
Why?
|
| Embolization, Therapeutic | 4 | 2024 | 1411 | 0.400 |
Why?
|
| Stem Cell Transplantation | 2 | 2019 | 1601 | 0.400 |
Why?
|
| Tumor Microenvironment | 7 | 2024 | 3826 | 0.390 |
Why?
|
| Cell Survival | 2 | 2019 | 5796 | 0.390 |
Why?
|
| Antineoplastic Agents | 3 | 2019 | 13629 | 0.380 |
Why?
|
| Cerebellar Diseases | 3 | 2023 | 219 | 0.380 |
Why?
|
| Hematoma, Subdural, Chronic | 2 | 2024 | 92 | 0.370 |
Why?
|
| Clobetasol | 2 | 2021 | 32 | 0.360 |
Why?
|
| Spinal Cord Injuries | 2 | 2021 | 923 | 0.350 |
Why?
|
| Transplantation Conditioning | 1 | 2017 | 1593 | 0.350 |
Why?
|
| Pituitary Neoplasms | 3 | 2024 | 1313 | 0.340 |
Why?
|
| Immunotherapy | 7 | 2024 | 4637 | 0.320 |
Why?
|
| Military Personnel | 2 | 2015 | 1245 | 0.310 |
Why?
|
| Skull Base Neoplasms | 3 | 2021 | 269 | 0.310 |
Why?
|
| T-Lymphocytes | 3 | 2024 | 10183 | 0.310 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2021 | 927 | 0.300 |
Why?
|
| Cerebral Hemorrhage | 4 | 2023 | 2660 | 0.300 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2019 | 198 | 0.290 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 3726 | 0.290 |
Why?
|
| Meningioma | 3 | 2020 | 1220 | 0.290 |
Why?
|
| DNA Modification Methylases | 2 | 2019 | 208 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 2895 | 0.280 |
Why?
|
| Animals | 36 | 2024 | 167940 | 0.280 |
Why?
|
| Aneurysm, Ruptured | 2 | 2023 | 460 | 0.280 |
Why?
|
| Wounds, Gunshot | 1 | 2012 | 581 | 0.270 |
Why?
|
| DNA Repair Enzymes | 2 | 2019 | 345 | 0.260 |
Why?
|
| Central Nervous System | 3 | 2023 | 1334 | 0.260 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 2135 | 0.250 |
Why?
|
| Hedgehog Proteins | 2 | 2021 | 769 | 0.250 |
Why?
|
| Thoracic Vertebrae | 3 | 2015 | 597 | 0.250 |
Why?
|
| Cerebellum | 3 | 2022 | 1495 | 0.250 |
Why?
|
| Cancer Vaccines | 2 | 2024 | 1044 | 0.240 |
Why?
|
| Child | 15 | 2024 | 79758 | 0.240 |
Why?
|
| Male | 47 | 2024 | 359413 | 0.230 |
Why?
|
| Cyclophosphamide | 2 | 2019 | 2220 | 0.220 |
Why?
|
| Pulmonary Embolism | 3 | 2021 | 2544 | 0.220 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2019 | 2804 | 0.220 |
Why?
|
| Postoperative Complications | 9 | 2024 | 15680 | 0.220 |
Why?
|
| Cisplatin | 2 | 2019 | 1642 | 0.220 |
Why?
|
| Hemangioma, Cavernous | 1 | 2023 | 107 | 0.210 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2023 | 56 | 0.210 |
Why?
|
| Adenoma | 2 | 2024 | 2148 | 0.210 |
Why?
|
| ACTH-Secreting Pituitary Adenoma | 1 | 2023 | 63 | 0.210 |
Why?
|
| Meningeal Neoplasms | 3 | 2020 | 1248 | 0.210 |
Why?
|
| Mice, Inbred CBA | 2 | 2022 | 436 | 0.210 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2023 | 65 | 0.210 |
Why?
|
| Veins | 2 | 2023 | 765 | 0.200 |
Why?
|
| Mice | 19 | 2024 | 81216 | 0.200 |
Why?
|
| Streptococcus anginosus | 1 | 2022 | 24 | 0.200 |
Why?
|
| Platelet Function Tests | 1 | 2024 | 303 | 0.200 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2023 | 140 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11708 | 0.200 |
Why?
|
| Nervous System Malformations | 1 | 2023 | 244 | 0.190 |
Why?
|
| Neural Tube Defects | 1 | 2023 | 254 | 0.190 |
Why?
|
| Skull | 2 | 2022 | 815 | 0.190 |
Why?
|
| Trephining | 1 | 2020 | 13 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 110 | 0.190 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2024 | 3201 | 0.190 |
Why?
|
| Retrospective Studies | 26 | 2024 | 80301 | 0.190 |
Why?
|
| Discitis | 1 | 2021 | 45 | 0.180 |
Why?
|
| Unfolded Protein Response | 1 | 2023 | 233 | 0.180 |
Why?
|
| Methylobacteriaceae | 1 | 2020 | 2 | 0.180 |
Why?
|
| Hospital Charges | 1 | 2023 | 359 | 0.180 |
Why?
|
| Valsalva Maneuver | 1 | 2020 | 98 | 0.180 |
Why?
|
| Tetraploidy | 1 | 2020 | 29 | 0.180 |
Why?
|
| Female | 43 | 2024 | 391011 | 0.180 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2021 | 58 | 0.180 |
Why?
|
| Motor Activity | 2 | 2021 | 2687 | 0.180 |
Why?
|
| Glucocorticoids | 2 | 2021 | 2143 | 0.180 |
Why?
|
| Thromboembolism | 2 | 2024 | 1016 | 0.180 |
Why?
|
| Platybasia | 1 | 2020 | 10 | 0.180 |
Why?
|
| Spinal Fusion | 4 | 2024 | 1280 | 0.180 |
Why?
|
| Hemangiopericytoma | 1 | 2020 | 71 | 0.170 |
Why?
|
| Cranial Sinuses | 1 | 2020 | 68 | 0.170 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2020 | 43 | 0.170 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2020 | 87 | 0.170 |
Why?
|
| Brain Stem Infarctions | 1 | 2020 | 31 | 0.170 |
Why?
|
| Venous Thrombosis | 2 | 2021 | 1293 | 0.170 |
Why?
|
| Eccrine Glands | 1 | 2020 | 52 | 0.170 |
Why?
|
| Cell Cycle | 2 | 2019 | 2937 | 0.170 |
Why?
|
| Metals | 1 | 2024 | 736 | 0.170 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2020 | 67 | 0.170 |
Why?
|
| Intracranial Pressure | 1 | 2022 | 325 | 0.170 |
Why?
|
| Thalassemia | 1 | 2020 | 270 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2015 | 3784 | 0.170 |
Why?
|
| Intracranial Hypertension | 1 | 2022 | 193 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 3 | 2020 | 2805 | 0.170 |
Why?
|
| Lomustine | 1 | 2019 | 60 | 0.170 |
Why?
|
| Equipment Failure | 2 | 2019 | 577 | 0.160 |
Why?
|
| Encephalocele | 1 | 2020 | 135 | 0.160 |
Why?
|
| Skull Neoplasms | 1 | 2020 | 173 | 0.160 |
Why?
|
| Spinal Cord Diseases | 1 | 2022 | 293 | 0.160 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2020 | 186 | 0.160 |
Why?
|
| Ventriculostomy | 1 | 2020 | 131 | 0.160 |
Why?
|
| Rupture, Spontaneous | 1 | 2019 | 356 | 0.160 |
Why?
|
| Nanostructures | 1 | 2024 | 547 | 0.160 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2020 | 326 | 0.160 |
Why?
|
| Thrombectomy | 1 | 2024 | 707 | 0.160 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2019 | 135 | 0.160 |
Why?
|
| Immunohistochemistry | 5 | 2024 | 11064 | 0.160 |
Why?
|
| Nasal Cavity | 1 | 2021 | 304 | 0.160 |
Why?
|
| Nose Neoplasms | 1 | 2021 | 249 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 36247 | 0.160 |
Why?
|
| Venous Thromboembolism | 2 | 2022 | 1866 | 0.160 |
Why?
|
| Medulla Oblongata | 1 | 2020 | 248 | 0.160 |
Why?
|
| Therapies, Investigational | 1 | 2019 | 111 | 0.160 |
Why?
|
| Head Injuries, Closed | 1 | 2019 | 133 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2020 | 534 | 0.150 |
Why?
|
| Etoposide | 1 | 2019 | 630 | 0.150 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2020 | 238 | 0.150 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2020 | 117 | 0.150 |
Why?
|
| Injections, Intralesional | 1 | 2019 | 278 | 0.150 |
Why?
|
| Cysts | 1 | 2023 | 683 | 0.150 |
Why?
|
| Radiation, Ionizing | 1 | 2019 | 251 | 0.150 |
Why?
|
| Vasospasm, Intracranial | 1 | 2020 | 214 | 0.150 |
Why?
|
| Spinal Puncture | 1 | 2020 | 281 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2024 | 16905 | 0.150 |
Why?
|
| Herpes Simplex | 1 | 2021 | 477 | 0.150 |
Why?
|
| Neuroimmunomodulation | 2 | 2016 | 177 | 0.150 |
Why?
|
| Astrocytoma | 2 | 2024 | 775 | 0.150 |
Why?
|
| Succinic Acid | 1 | 2018 | 84 | 0.150 |
Why?
|
| Prostheses and Implants | 1 | 2024 | 1272 | 0.150 |
Why?
|
| Status Epilepticus | 1 | 2023 | 456 | 0.140 |
Why?
|
| Treatment Outcome | 16 | 2024 | 64947 | 0.140 |
Why?
|
| Oxygen | 3 | 2019 | 4189 | 0.140 |
Why?
|
| Vincristine | 1 | 2019 | 1038 | 0.140 |
Why?
|
| Neurosurgery | 1 | 2024 | 670 | 0.140 |
Why?
|
| Combined Modality Therapy | 4 | 2024 | 8551 | 0.140 |
Why?
|
| Middle Cerebral Artery | 3 | 2023 | 275 | 0.140 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2021 | 549 | 0.140 |
Why?
|
| Neurons | 6 | 2023 | 9416 | 0.140 |
Why?
|
| Brain Edema | 1 | 2021 | 603 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2020 | 593 | 0.140 |
Why?
|
| Melanoma, Experimental | 1 | 2020 | 562 | 0.140 |
Why?
|
| Cell Line, Transformed | 1 | 2018 | 871 | 0.140 |
Why?
|
| Adult | 24 | 2024 | 219847 | 0.130 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 1760 | 0.130 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2019 | 367 | 0.130 |
Why?
|
| Brain | 7 | 2024 | 26912 | 0.130 |
Why?
|
| Motor Neurons | 1 | 2021 | 865 | 0.130 |
Why?
|
| Child, Preschool | 6 | 2021 | 42034 | 0.130 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2017 | 110 | 0.130 |
Why?
|
| Carboplatin | 1 | 2019 | 789 | 0.130 |
Why?
|
| Quercetin | 1 | 2016 | 97 | 0.130 |
Why?
|
| Ribosomal Protein S6 | 1 | 2015 | 71 | 0.130 |
Why?
|
| Asparaginase | 1 | 2017 | 240 | 0.130 |
Why?
|
| Cerebral Veins | 1 | 2017 | 157 | 0.130 |
Why?
|
| Hibernation | 1 | 2015 | 47 | 0.130 |
Why?
|
| Conjugation, Genetic | 1 | 2015 | 121 | 0.130 |
Why?
|
| Tyrosine | 1 | 2020 | 1440 | 0.130 |
Why?
|
| Galectin 3 | 1 | 2017 | 240 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 788 | 0.130 |
Why?
|
| Signal Transduction | 6 | 2024 | 23363 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 2536 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 1173 | 0.120 |
Why?
|
| Cell Cycle Proteins | 2 | 2021 | 3448 | 0.120 |
Why?
|
| Ischemic Preconditioning | 1 | 2015 | 89 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1090 | 0.120 |
Why?
|
| Drainage | 1 | 2020 | 1161 | 0.120 |
Why?
|
| Osteosarcoma | 1 | 2021 | 898 | 0.120 |
Why?
|
| Vaccines | 1 | 2023 | 833 | 0.120 |
Why?
|
| Spinal Fractures | 1 | 2021 | 698 | 0.120 |
Why?
|
| Rats | 5 | 2018 | 23695 | 0.120 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 1442 | 0.120 |
Why?
|
| Thymus Gland | 1 | 2019 | 1246 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2017 | 346 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10434 | 0.120 |
Why?
|
| Adjuvants, Immunologic | 1 | 2020 | 1041 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2019 | 945 | 0.120 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2016 | 254 | 0.120 |
Why?
|
| Internal Fixators | 1 | 2015 | 183 | 0.110 |
Why?
|
| Surgical Wound Infection | 2 | 2020 | 1529 | 0.110 |
Why?
|
| Dendritic Spines | 1 | 2015 | 243 | 0.110 |
Why?
|
| Intracranial Hemorrhages | 1 | 2019 | 844 | 0.110 |
Why?
|
| Middle Aged | 25 | 2024 | 220175 | 0.110 |
Why?
|
| Brain Stem | 1 | 2019 | 857 | 0.110 |
Why?
|
| Afghan Campaign 2001- | 1 | 2015 | 296 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2015 | 778 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 620 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2020 | 6131 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 9531 | 0.110 |
Why?
|
| Bacteremia | 1 | 2020 | 979 | 0.110 |
Why?
|
| Spinal Neoplasms | 1 | 2020 | 716 | 0.110 |
Why?
|
| Seizures | 2 | 2023 | 2916 | 0.110 |
Why?
|
| Remission Induction | 1 | 2019 | 2394 | 0.110 |
Why?
|
| Aged | 19 | 2024 | 168995 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 938 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2019 | 933 | 0.110 |
Why?
|
| Microglia | 1 | 2022 | 1348 | 0.110 |
Why?
|
| Cerebral Cortex | 5 | 2017 | 5755 | 0.110 |
Why?
|
| Dendrites | 1 | 2015 | 475 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 1347 | 0.100 |
Why?
|
| Multiple Sclerosis | 2 | 2020 | 3202 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2024 | 3584 | 0.100 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 1428 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2019 | 855 | 0.100 |
Why?
|
| Virus Replication | 1 | 2020 | 2431 | 0.100 |
Why?
|
| Sialic Acids | 1 | 2012 | 122 | 0.100 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2012 | 44 | 0.100 |
Why?
|
| Cohort Studies | 8 | 2023 | 41317 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2017 | 5039 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 485 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 1297 | 0.100 |
Why?
|
| DNA, Viral | 1 | 2019 | 2195 | 0.100 |
Why?
|
| Length of Stay | 2 | 2023 | 6472 | 0.100 |
Why?
|
| Macrophages | 2 | 2018 | 5745 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 1999 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2022 | 1915 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2021 | 2869 | 0.100 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2016 | 498 | 0.100 |
Why?
|
| Laminectomy | 1 | 2012 | 224 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2015 | 322 | 0.100 |
Why?
|
| Infant | 4 | 2023 | 36030 | 0.100 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 39254 | 0.090 |
Why?
|
| Reoperation | 2 | 2019 | 4292 | 0.090 |
Why?
|
| Reperfusion Injury | 1 | 2018 | 1023 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2020 | 1843 | 0.090 |
Why?
|
| Brain Diseases | 1 | 2020 | 1540 | 0.090 |
Why?
|
| Materials Testing | 1 | 2014 | 858 | 0.090 |
Why?
|
| Anticoagulants | 3 | 2021 | 4896 | 0.090 |
Why?
|
| Temporal Arteries | 2 | 2022 | 148 | 0.090 |
Why?
|
| Memory | 1 | 2020 | 2179 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2021 | 1634 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2015 | 532 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2021 | 2641 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 1459 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 1870 | 0.090 |
Why?
|
| Adolescent | 8 | 2024 | 87747 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 734 | 0.090 |
Why?
|
| Survival Rate | 2 | 2024 | 12806 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 18134 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 943 | 0.080 |
Why?
|
| Mutation | 3 | 2021 | 29950 | 0.080 |
Why?
|
| Osteotomy | 1 | 2015 | 835 | 0.080 |
Why?
|
| Glasgow Coma Scale | 2 | 2021 | 579 | 0.080 |
Why?
|
| Proteome | 1 | 2019 | 1856 | 0.080 |
Why?
|
| Telomere | 1 | 2015 | 934 | 0.080 |
Why?
|
| Sarcoma | 1 | 2020 | 1786 | 0.080 |
Why?
|
| Neuroglia | 1 | 2015 | 944 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2020 | 1939 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 2012 | 959 | 0.080 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2020 | 334 | 0.080 |
Why?
|
| Carcinoma | 1 | 2020 | 2334 | 0.080 |
Why?
|
| Incidence | 4 | 2024 | 21378 | 0.080 |
Why?
|
| Cell Line | 2 | 2019 | 15626 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 2811 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2020 | 2500 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2020 | 20484 | 0.070 |
Why?
|
| Mitochondria | 1 | 2021 | 3598 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 8058 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10829 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2015 | 1758 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 1266 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3504 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 3023 | 0.070 |
Why?
|
| Hospitals | 1 | 2020 | 3929 | 0.070 |
Why?
|
| Gene Expression | 1 | 2019 | 7592 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4923 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4554 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 22025 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2021 | 18968 | 0.070 |
Why?
|
| Patient Readmission | 1 | 2020 | 3327 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 2880 | 0.060 |
Why?
|
| Cerebral Angiography | 2 | 2021 | 1272 | 0.060 |
Why?
|
| Oligodendroglia | 2 | 2020 | 535 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5230 | 0.060 |
Why?
|
| Adhesives | 1 | 2024 | 64 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 12968 | 0.060 |
Why?
|
| Prognosis | 5 | 2023 | 29636 | 0.060 |
Why?
|
| Radiography | 1 | 2014 | 6965 | 0.050 |
Why?
|
| Poly I | 1 | 2022 | 5 | 0.050 |
Why?
|
| Cranial Nerves | 1 | 2023 | 98 | 0.050 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2023 | 45 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9388 | 0.050 |
Why?
|
| Prevalence | 2 | 2020 | 15687 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2024 | 358 | 0.050 |
Why?
|
| Retreatment | 1 | 2024 | 600 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 248 | 0.050 |
Why?
|
| Acyclovir | 1 | 2023 | 269 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2024 | 244 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 2731 | 0.050 |
Why?
|
| Dura Mater | 1 | 2023 | 290 | 0.050 |
Why?
|
| Carotid Artery, Internal | 1 | 2023 | 438 | 0.050 |
Why?
|
| Electrolytes | 1 | 2022 | 280 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2017 | 8157 | 0.050 |
Why?
|
| Death, Sudden | 1 | 2023 | 302 | 0.050 |
Why?
|
| Models, Biological | 1 | 2017 | 9468 | 0.050 |
Why?
|
| Astrocytes | 2 | 2020 | 1335 | 0.050 |
Why?
|
| Glossopharyngeal Nerve Diseases | 1 | 2020 | 10 | 0.050 |
Why?
|
| Catheters | 1 | 2024 | 425 | 0.050 |
Why?
|
| Pituitary Gland | 1 | 2023 | 637 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 373 | 0.040 |
Why?
|
| Tyrosine Transaminase | 1 | 2020 | 11 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2012 | 2044 | 0.040 |
Why?
|
| Hemifacial Spasm | 1 | 2020 | 24 | 0.040 |
Why?
|
| Drug Delivery Systems | 2 | 2023 | 2218 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 8595 | 0.040 |
Why?
|
| Mitochondria, Muscle | 1 | 2021 | 172 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2023 | 481 | 0.040 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2020 | 19 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 1 | 2020 | 193 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2023 | 657 | 0.040 |
Why?
|
| Odontoid Process | 1 | 2020 | 43 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2023 | 581 | 0.040 |
Why?
|
| Carcinoma, Ductal | 1 | 2020 | 98 | 0.040 |
Why?
|
| Young Adult | 3 | 2024 | 58673 | 0.040 |
Why?
|
| Vaccination | 2 | 2023 | 3360 | 0.040 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2020 | 100 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 58947 | 0.040 |
Why?
|
| Trigeminal Neuralgia | 1 | 2020 | 106 | 0.040 |
Why?
|
| Diverticulum | 1 | 2020 | 137 | 0.040 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2021 | 346 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2023 | 475 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2020 | 293 | 0.040 |
Why?
|
| Cholera Toxin | 1 | 2021 | 559 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 1723 | 0.040 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2020 | 177 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2020 | 305 | 0.040 |
Why?
|
| Organ Size | 1 | 2023 | 2249 | 0.040 |
Why?
|
| Abdominal Wall | 1 | 2020 | 166 | 0.040 |
Why?
|
| World Health Organization | 1 | 2024 | 1319 | 0.040 |
Why?
|
| Nitrogen | 1 | 2020 | 350 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 6545 | 0.040 |
Why?
|
| Abscess | 1 | 2022 | 605 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2020 | 328 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10757 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2019 | 195 | 0.040 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2557 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2022 | 1084 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11341 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 5797 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11902 | 0.040 |
Why?
|
| Skull Base | 1 | 2020 | 291 | 0.040 |
Why?
|
| Epitopes | 1 | 2024 | 2506 | 0.040 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 12532 | 0.040 |
Why?
|
| Karnofsky Performance Status | 1 | 2017 | 165 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 523 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2023 | 54263 | 0.040 |
Why?
|
| Syndrome | 1 | 2023 | 3278 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2020 | 495 | 0.040 |
Why?
|
| Scalp | 1 | 2020 | 389 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2021 | 1600 | 0.040 |
Why?
|
| Adult Stem Cells | 1 | 2019 | 221 | 0.040 |
Why?
|
| Dogs | 1 | 2022 | 3843 | 0.030 |
Why?
|
| Tongue Diseases | 1 | 2017 | 68 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2016 | 225 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 5784 | 0.030 |
Why?
|
| Biological Transport | 1 | 2021 | 2087 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2016 | 413 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2018 | 370 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2023 | 1478 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 495 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2015 | 186 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2021 | 4374 | 0.030 |
Why?
|
| Sciuridae | 1 | 2015 | 78 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 2056 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2023 | 1817 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 1790 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2023 | 15273 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2016 | 412 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2018 | 599 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2020 | 730 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1897 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2015 | 226 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2020 | 2627 | 0.030 |
Why?
|
| Galectins | 1 | 2017 | 282 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1156 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2023 | 1853 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 1388 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2020 | 732 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8498 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1739 | 0.030 |
Why?
|
| Disease Progression | 2 | 2024 | 13505 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2022 | 1784 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 657 | 0.030 |
Why?
|
| Chemokines | 1 | 2018 | 962 | 0.030 |
Why?
|
| Age Factors | 2 | 2021 | 18415 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2019 | 2646 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 616 | 0.030 |
Why?
|
| Risk Factors | 4 | 2021 | 74269 | 0.030 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2012 | 18 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2021 | 22041 | 0.030 |
Why?
|
| Prostate | 1 | 2021 | 1793 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1882 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14396 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 3605 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2017 | 1172 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 2204 | 0.020 |
Why?
|
| Aspirin | 1 | 2024 | 3365 | 0.020 |
Why?
|
| Swine | 1 | 2022 | 5902 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 724 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3618 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2016 | 1375 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2024 | 3604 | 0.020 |
Why?
|
| United States | 2 | 2020 | 72363 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 3531 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2852 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 825 | 0.020 |
Why?
|
| Cell Death | 1 | 2016 | 1670 | 0.020 |
Why?
|
| Cadaver | 1 | 2015 | 1345 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2023 | 10185 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2024 | 3475 | 0.020 |
Why?
|
| Metabolomics | 1 | 2020 | 1626 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1244 | 0.020 |
Why?
|
| Inpatients | 1 | 2022 | 2578 | 0.020 |
Why?
|
| Radiosurgery | 1 | 2019 | 1343 | 0.020 |
Why?
|
| DNA | 1 | 2024 | 7236 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 999 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2019 | 3378 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2011 | 195 | 0.020 |
Why?
|
| Stents | 1 | 2021 | 3303 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2021 | 9712 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8487 | 0.020 |
Why?
|
| Base Sequence | 1 | 2020 | 12447 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5420 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12762 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 1582 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2020 | 1938 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2016 | 1252 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 2017 | 2108 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2023 | 6562 | 0.020 |
Why?
|
| Hippocampus | 1 | 2020 | 3737 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3758 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2016 | 4127 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3443 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3526 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2024 | 9196 | 0.020 |
Why?
|
| Medicaid | 1 | 2020 | 2811 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 1056 | 0.020 |
Why?
|
| Graft Survival | 1 | 2016 | 3793 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 8018 | 0.020 |
Why?
|
| Phenotype | 1 | 2023 | 16543 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20048 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6775 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2017 | 4437 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 2049 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3046 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2015 | 8314 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12602 | 0.010 |
Why?
|
| Apoptosis | 1 | 2020 | 9497 | 0.010 |
Why?
|
| Cognition | 1 | 2020 | 6948 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9283 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17628 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11480 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2015 | 4938 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2012 | 2982 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 17766 | 0.010 |
Why?
|
| Neoplasms | 1 | 2011 | 22066 | 0.010 |
Why?
|
| DNA Repair | 1 | 2011 | 2039 | 0.010 |
Why?
|
| Bone Density | 1 | 2014 | 3528 | 0.010 |
Why?
|
| DNA Damage | 1 | 2011 | 2442 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8945 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13249 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 29725 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 40133 | 0.010 |
Why?
|